fulvestrant has been researched along with Hypertension, Pulmonary in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Austin, ED; Brittain, EL; Chen, X; Farber-Eger, EH; Fessel, JP; Hemnes, AR; Loyd, JE; Talati, M; West, J | 1 |
Baden, H; Ichimori, H; Ishida, H; Kogaki, S; Narita, J; Nawa, N; Okada, Y; Ozono, K; Takahashi, K; Uchikawa, T | 1 |
Artem'eva, MM; Kovaleva, IuO; Medvedev, OS; Medvedeva, NA | 1 |
Albrecht, M; Brown, JA; Brown, MB; Dieudonne, D; Fisher, AJ; Justice, MJ; Lahm, T; Patel, NG; Petrache, I; Presson, RG; Reddy, JG; Selej, M; Trulock, KM; Van Demark, M | 1 |
Hill, NS; Karamsetty, MR; Klinger, JR | 1 |
5 other study(ies) available for fulvestrant and Hypertension, Pulmonary
Article | Year |
---|---|
Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects.
Topics: Anastrozole; Animals; Bone Morphogenetic Protein Receptors, Type II; Disease Models, Animal; Echocardiography; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Hemodynamics; Humans; Hypertension, Pulmonary; Insulin Resistance; Lung; Mice; Mice, Knockout; Mutation; Nitriles; Signal Transduction; Tamoxifen; Triazoles | 2017 |
Drastic shift from positive to negative estrogen effect on bone morphogenetic protein signaling in pulmonary arterial endothelial cells under hypoxia.
Topics: Bone Morphogenetic Proteins; Cell Hypoxia; Cells, Cultured; Cycloheximide; Endothelial Cells; Estradiol; Estrogen Antagonists; Estrogens; Fulvestrant; Humans; Hypertension, Pulmonary; Hypoxia-Inducible Factor 1, alpha Subunit; Protein Synthesis Inhibitors; Pulmonary Artery; Signal Transduction; Smad Proteins | 2013 |
[Chronic administration of estrogen receptors antagonist reduces degree of hypoxia-induced pulmonary hypertension caused by chronic injections of estrogen in ovariectomised female Wistar rats].
Topics: Animals; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Familial Primary Pulmonary Hypertension; Female; Fulvestrant; Hypertension, Pulmonary; Hypoxia; Ovariectomy; Rats; Rats, Wistar | 2013 |
17β-Estradiol attenuates hypoxic pulmonary hypertension via estrogen receptor-mediated effects.
Topics: Airway Remodeling; Animals; Blood Pressure; Cardiac Output; Cyclin-Dependent Kinase Inhibitor p27; Estradiol; Estrogen Antagonists; Fulvestrant; Hypertension, Pulmonary; Hypoxia; Lung; Male; Neovascularization, Pathologic; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Ventricular Remodeling | 2012 |
Phytoestrogens restore nitric oxide-mediated relaxation in isolated pulmonary arteries from chronically hypoxic rats.
Topics: Animals; Carbachol; Cholinergic Agonists; Chronic Disease; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogens, Non-Steroidal; Fulvestrant; Genistein; Hypertension, Pulmonary; Hypoxia; In Vitro Techniques; Isoflavones; Male; Nitric Oxide; Nitric Oxide Synthase; Phytoestrogens; Plant Preparations; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2001 |